期刊文献+

舒张功能不全性心衰72例治疗体会

Experience of treating 72 cases of DHF
下载PDF
导出
摘要 目的:对72例舒张功能不全性心衰患者进行临床分析。方法:在积极进行病因治疗的同时,应用利尿剂和硝酸酯类药物缓解症状,常规选用血管紧张素转换酶抑制剂(ACEI)或血管紧张素Ⅱ受体拮抗剂(ARB)、β受体阻滞剂及钙离子拮抗剂以改善左室舒张功能。人院时及治疗4周后分别行彩色多普勒超声心动图检查,用流速指标测定二尖瓣血流图E/A比值,并观察心功能(NYHA分级)改善情况。结论:舒张性心衰主要病因为高血压和冠心病,且随着年龄的增长,发病率呈增加趋势。房颤、心动过速可加重临床症状,应积极纠正,控制心室率在60~70次/min。小剂量开始应用利尿剂、硝酸酯类药物,β受体阻滞剂开始剂量较大,调整剂量不受时间限制。 Objective: To analyze 72 cases of DHF in patients. Methods: Active cause of treatment, at the same time, using diuretics and nitrates to relieve symptoms, the conventional choice of angiotensin-converting enzyme inhibitors (ACEI) or angiotensin Ⅱ receptor antagonist (ARB), ,8 blockers agents and calcium channel blockers to improve left ventricular diastolic function. Color doppler echocardiography were performed after admission and treatment of four weeks, using flow rate indicator to determine the mitral rheogram E/A ratio, and to.observe the improvement of NYHA. Conclusion: Hypertension and coronary heart disease are the main causes of diastolic heart failure, and with the increase of age, the incidence rate showed an increasing trend. Atrial fibrillation, tachycardia may aggravate the clinical symptoms, should be actively corrected, the ventricular rate control in 60-70 beats/min. Dosage should be appropriate.
作者 王红
出处 《中医临床研究》 2012年第15期61-62,共2页 Clinical Journal Of Chinese Medicine
关键词 舒张功能不全性心衰 治疗 DHF Treatment
  • 相关文献

参考文献3

二级参考文献29

  • 1European Study Group on Diastolic Heart Failure. How to diagnose diastolic heart failure[J]. Eur Heart J, 1998,19(7) :990-1003.
  • 2Vasan RS, Levy D. Defining diastolic heart failure : a call for standardized diagnostic criteria[J] .Circulation,2000,101(17) :2118-2121.
  • 3Zile MR, Gaasch WH, Carroll JD, et al. Heart failure with a normal ejection fraction : is measurement of diastolic function necessary tomake the diagnosis of diastolic leart failure? [J]. Circulation,2001,104(4):779-782.
  • 4Zile MR, Brutsaert DL. New concepts in diastolic dysfunction anddiastolic heart failure : Part Ⅱ : causal mechanisms and treatment [ J ]. Circulation,2002,105(12) : 1503-1508.
  • 5Bergstrom A, Andersson B, Edner M, et al. Effect of earvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study(SWEDIC) [J]. Eur J Heart Fail,2004,6(4):453-461.
  • 6Yusuf S, Pfeffer MA, Swedberg K, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction : the CHARM-Preserved Trial [ J ]. Lancet, 2003,362 (9386) :777-781.
  • 7The Digitalis Lnvestigation Group. The effect of digoxin on morality and mortbidity in patients with heart failure[J]. N Engl J Med, 1997,336(8) :525-533.
  • 8Yamamoto K, Masuyama T, Sakata Y, et al. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventficular structural remodeling in inhibition of ventricular structural remodeling in hypertensive heart [ J ]. J Hypertens, 2002,20 (4) : 753-761.
  • 9Kitzman DW, Gardin JM, Gottdiener JS, et al. Importance of heart failure with preserved systolic function in patients ≥ 65 years of age. CHS Research Group[ J]. Am J Cardiol, 2001,87 (4) :413-419.
  • 10Sean H, Denise S, Zijian Xu. Diastolic Heart Failure : A review and primary care perspective[ J]. J Am Board Fam Pract, 2005, 18 (3) : 189-198.

共引文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部